RARITAN, N.J., Sept. 17Â -- The U.S. Food and Drug Administration (FDA) has approved use of the five-day, once-daily regimen of LEVAQUIN(R) (levofloxacin) 750 mg I.V. and oral, for the treatment of ...
The U.S. Food and Drug Administration today approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older. Levofloxacin ...
COLUMBUS, GA (WTVM) - In a News Leader 9 investigation—a antibiotic known by the brand name of ‘Levaquin’ is garnering national attention by medical researchers and doctors. Dr. Charles Bennett, who ...
Jan. 19, 2005 — The U.S. Food and Drug Administration (FDA) approved last October revisions to safety labeling to advise healthcare professionals of the following changes: ramipril may be linked to ...
FDA Extends Marketing Exclusivity for LEVAQUIN RARITAN, N.J., March 14 -- The U.S. Food and Drug Administration (FDA) has granted LEVAQUIN(R) (levofloxacin) an additional six months of marketing ...
June 21, 2011 — The US Food and Drug Administration (FDA) yesterday approved applications from 12 companies to manufacture generic versions of levofloxacin (Levaquin, Ortho-McNeil-Janssen ...
AMITYVILLE, N.Y. — A generic version of a popular pneumonia treatment has entered the market from Hi-Tech Pharmacal. Hi-Tech Pharmacal has introduced levofloxacin oral solution in the 25-mg/mL ...
Please provide your email address to receive an email when new articles are posted on . Two phase 3 trials showed levofloxacin reduces the risk for multidrug-resistant TB after household exposure.
They tend to be more persistent in adults, some lasting five to seven years, but always go eventually due to the actions of the immune system. Anogenital warts require specialist diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback